Matches in SemOpenAlex for { <https://semopenalex.org/work/W2769058266> ?p ?o ?g. }
- W2769058266 abstract "ABSTRACT The well-characterized association between HLA-B*27:05 and protection against HIV disease progression has been linked to immunodominant HLA-B*27:05-restricted CD8 + T-cell responses toward the conserved Gag KK10 (residues 263 to 272) and polymerase (Pol) KY9 (residues 901 to 909) epitopes. We studied the impact of the 3 amino acid differences between HLA-B*27:05 and the closely related HLA-B*27:02 on the HIV-specific CD8 + T-cell response hierarchy and on immune control of HIV. Genetic epidemiological data indicate that both HLA-B*27:02 and HLA-B*27:05 are associated with slower disease progression and lower viral loads. The effect of HLA-B*27:02 appeared to be consistently stronger than that of HLA-B*27:05. In contrast to HLA-B*27:05, the immunodominant HIV-specific HLA-B*27:02-restricted CD8 + T-cell response is to a Nef epitope (residues 142 to 150 [VW9]), with Pol KY9 subdominant and Gag KK10 further subdominant. This selection was driven by structural differences in the F pocket, mediated by a polymorphism between these two HLA alleles at position 81. Analysis of autologous virus sequences showed that in HLA-B*27:02-positive subjects, all three of these CD8 + T-cell responses impose selection pressure on the virus, whereas in HLA-B*27:05-positive subjects, there is no Nef VW9-mediated selection pressure. These studies demonstrate that HLA-B*27:02 mediates protection against HIV disease progression that is at least as strong as or stronger than that mediated by HLA-B*27:05. In combination with the protective Gag KK10 and Pol KY9 CD8 + T-cell responses that dominate HIV-specific CD8 + T-cell activity in HLA-B*27:05-positive subjects, a Nef VW9-specific response is additionally present and immunodominant in HLA-B*27:02-positive subjects, mediated through a polymorphism at residue 81 in the F pocket, that contributes to selection pressure against HIV. IMPORTANCE CD8 + T cells play a central role in successful control of HIV infection and have the potential also to mediate the eradication of viral reservoirs of infection. The principal means by which protective HLA class I molecules, such as HLA-B*27:05 and HLA-B*57:01, slow HIV disease progression is believed to be via the particular HIV-specific CD8 + T cell responses restricted by those alleles. We focus here on HLA-B*27:05, one of the best-characterized protective HLA molecules, and the closely related HLA-B*27:02, which differs by only 3 amino acids and which has not been well studied in relation to control of HIV infection. We show that HLA-B*27:02 is also protective against HIV disease progression, but the CD8 + T-cell immunodominance hierarchy of HLA-B*27:02 differs strikingly from that of HLA-B*27:05. These findings indicate that the immunodominant HLA-B*27:02-restricted Nef response adds to protection mediated by the Gag and Pol specificities that dominate anti-HIV CD8 + T-cell activity in HLA-B*27:05-positive subjects." @default.
- W2769058266 created "2017-12-04" @default.
- W2769058266 creator A5002690478 @default.
- W2769058266 creator A5004709847 @default.
- W2769058266 creator A5004800654 @default.
- W2769058266 creator A5006254248 @default.
- W2769058266 creator A5009636499 @default.
- W2769058266 creator A5015124189 @default.
- W2769058266 creator A5015421077 @default.
- W2769058266 creator A5018290358 @default.
- W2769058266 creator A5018523831 @default.
- W2769058266 creator A5020425530 @default.
- W2769058266 creator A5022694581 @default.
- W2769058266 creator A5025067591 @default.
- W2769058266 creator A5025642389 @default.
- W2769058266 creator A5028738992 @default.
- W2769058266 creator A5029251146 @default.
- W2769058266 creator A5034309741 @default.
- W2769058266 creator A5034962623 @default.
- W2769058266 creator A5037721691 @default.
- W2769058266 creator A5038362714 @default.
- W2769058266 creator A5041703839 @default.
- W2769058266 creator A5042081819 @default.
- W2769058266 creator A5043346206 @default.
- W2769058266 creator A5043868687 @default.
- W2769058266 creator A5044530527 @default.
- W2769058266 creator A5045799253 @default.
- W2769058266 creator A5049253273 @default.
- W2769058266 creator A5050335754 @default.
- W2769058266 creator A5054617732 @default.
- W2769058266 creator A5056187765 @default.
- W2769058266 creator A5065065049 @default.
- W2769058266 creator A5068280445 @default.
- W2769058266 creator A5070165631 @default.
- W2769058266 creator A5080704945 @default.
- W2769058266 creator A5083219751 @default.
- W2769058266 creator A5083545834 @default.
- W2769058266 creator A5086435379 @default.
- W2769058266 creator A5086496217 @default.
- W2769058266 creator A5088996103 @default.
- W2769058266 creator A5089009771 @default.
- W2769058266 creator A5090367243 @default.
- W2769058266 date "2018-02-15" @default.
- W2769058266 modified "2023-10-09" @default.
- W2769058266 title "Differential Immunodominance Hierarchy of CD8 <sup>+</sup> T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection" @default.
- W2769058266 cites W1522955777 @default.
- W2769058266 cites W1971344747 @default.
- W2769058266 cites W1986152436 @default.
- W2769058266 cites W1990123254 @default.
- W2769058266 cites W2003313366 @default.
- W2769058266 cites W2017676871 @default.
- W2769058266 cites W2018529476 @default.
- W2769058266 cites W2022617508 @default.
- W2769058266 cites W2024218493 @default.
- W2769058266 cites W2035555649 @default.
- W2769058266 cites W2036766604 @default.
- W2769058266 cites W2043414210 @default.
- W2769058266 cites W2045043379 @default.
- W2769058266 cites W2057912460 @default.
- W2769058266 cites W2058321555 @default.
- W2769058266 cites W2071220222 @default.
- W2769058266 cites W2072132286 @default.
- W2769058266 cites W2072304983 @default.
- W2769058266 cites W2075906228 @default.
- W2769058266 cites W2076058809 @default.
- W2769058266 cites W2076412991 @default.
- W2769058266 cites W2078844183 @default.
- W2769058266 cites W2080872140 @default.
- W2769058266 cites W2085256975 @default.
- W2769058266 cites W2085716095 @default.
- W2769058266 cites W2088204382 @default.
- W2769058266 cites W2092368847 @default.
- W2769058266 cites W2094562745 @default.
- W2769058266 cites W2095603321 @default.
- W2769058266 cites W2103314023 @default.
- W2769058266 cites W2105571187 @default.
- W2769058266 cites W2109130469 @default.
- W2769058266 cites W2112341438 @default.
- W2769058266 cites W2118507973 @default.
- W2769058266 cites W2120529419 @default.
- W2769058266 cites W2124026197 @default.
- W2769058266 cites W2126325079 @default.
- W2769058266 cites W2129174937 @default.
- W2769058266 cites W2132262344 @default.
- W2769058266 cites W2138594667 @default.
- W2769058266 cites W2143430982 @default.
- W2769058266 cites W2145004838 @default.
- W2769058266 cites W2146366486 @default.
- W2769058266 cites W2146721994 @default.
- W2769058266 cites W2147134928 @default.
- W2769058266 cites W2147682824 @default.
- W2769058266 cites W2147745287 @default.
- W2769058266 cites W2148323928 @default.
- W2769058266 cites W2148814575 @default.
- W2769058266 cites W2150991884 @default.
- W2769058266 cites W2151326236 @default.
- W2769058266 cites W2151651155 @default.
- W2769058266 cites W2153778605 @default.
- W2769058266 cites W2155844694 @default.
- W2769058266 cites W2164861987 @default.